ClinicalTrials.gg
Sign In

Biological

FANG vaccine clinical trials

studies test it
11
open now
0
in phase 3
1
first study started
2009

How studies write it

Studies that test it under each name

Name

Vigil™ Vaccine
2
formerly known as FANG™
2

Combined with it in one product

Vigil
9
bi-shRNAfurin and GMCSF Autologous Tumor Cell Immunotherapy
5
FANG vaccine
3
Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy
3
formerly known as FANG™
3
formerly known as FANG™ vaccine
2
bi-shRNAfurin and GMCSF Augmented Autologous Tumor
1
Cell Vaccine
1

Studies by the year they started

11 studies that test it; most in 2016 (3)

Studies that test FANG vaccine, by start year
YearStudies
20091
20112
20121
20152
20163
20171
20181

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
8
Phase 3
1

What it is tested for

Each study’s main condition, where its own words name it.

Ovarian Neoplasms
4
Carcinoma, Non-Small-Cell Lung
2
Melanoma
2
Sarcoma, Ewing
1
Neoplasms
1
Carcinoma
1

Who runs them

Industry 10 · Other 1

Gradalis, Inc. (10) · Mary Crowley Medical Research Center (1)

Often tested with

Tested in the same studies.

Diclobutrazol (9) · Temozolomide (2) · Irinotecan (2) · Durvalumab (1) · Pembrolizumab (1) · Nivolumab (1)

Studies

Open first, then newest update. How each study uses FANG vaccine is read from its arms, and is right about nine times in ten.

Testing it · 11

Given in every arm · 2 — FANG vaccine is usual care beside what is tested
As the comparator · 1 — what is tested is compared with FANG vaccine